Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-10-17

FDA Approved: VOLTAREN ARTHRITIS PAIN — Original Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved Voltaren Arthritis Pain (diclofenac sodium) under an original NDA from Haleon US Holdings LLC for relief of osteoarthritis pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Voltaren Arthritis Pain (Diclofenac sodium)

Snippet

ORIG AP for VOLTAREN ARTHRITIS PAIN (DICLOFENAC SODIUM)